JP2010530380A5 - - Google Patents

Download PDF

Info

Publication number
JP2010530380A5
JP2010530380A5 JP2010512555A JP2010512555A JP2010530380A5 JP 2010530380 A5 JP2010530380 A5 JP 2010530380A5 JP 2010512555 A JP2010512555 A JP 2010512555A JP 2010512555 A JP2010512555 A JP 2010512555A JP 2010530380 A5 JP2010530380 A5 JP 2010530380A5
Authority
JP
Japan
Prior art keywords
phenyl
methyl
pyrrol
piperazin
ethane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010512555A
Other languages
English (en)
Japanese (ja)
Other versions
JP5371969B2 (ja
JP2010530380A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/004459 external-priority patent/WO2008155022A1/en
Publication of JP2010530380A publication Critical patent/JP2010530380A/ja
Publication of JP2010530380A5 publication Critical patent/JP2010530380A5/ja
Application granted granted Critical
Publication of JP5371969B2 publication Critical patent/JP5371969B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010512555A 2007-06-18 2008-06-04 P2y12拮抗薬としてのピロール誘導体 Expired - Fee Related JP5371969B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07290755.3 2007-06-18
EP07290755 2007-06-18
PCT/EP2008/004459 WO2008155022A1 (en) 2007-06-18 2008-06-04 Pyrrole derivatives as p2y12 antagonists

Publications (3)

Publication Number Publication Date
JP2010530380A JP2010530380A (ja) 2010-09-09
JP2010530380A5 true JP2010530380A5 (enExample) 2011-07-07
JP5371969B2 JP5371969B2 (ja) 2013-12-18

Family

ID=39092503

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010512555A Expired - Fee Related JP5371969B2 (ja) 2007-06-18 2008-06-04 P2y12拮抗薬としてのピロール誘導体

Country Status (12)

Country Link
US (1) US7910576B2 (enExample)
EP (1) EP2167487B1 (enExample)
JP (1) JP5371969B2 (enExample)
KR (1) KR20100020478A (enExample)
CN (1) CN101679358B (enExample)
AU (1) AU2008266515B2 (enExample)
BR (1) BRPI0812912A2 (enExample)
CA (1) CA2690243A1 (enExample)
IL (1) IL202758A (enExample)
MX (1) MX2009013431A (enExample)
MY (1) MY148901A (enExample)
WO (1) WO2008155022A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2102195A1 (en) 2006-10-20 2009-09-23 Novartis AG Crystal modifications -3- (1h-ind0l-3-yl) -4- [2- (4-methyl-piperazin-1-yl) -quinazolin-4-yl]-pyrrole-2, 5-d ione
EP2750676B1 (en) 2011-08-30 2018-01-10 University of Utah Research Foundation Methods and compositions for treating nephrogenic diabetes insipidus
DE102014108210A1 (de) 2014-06-11 2015-12-17 Dietrich Gulba Rodentizid
IL286902B2 (en) 2019-04-03 2025-03-01 Aligos Therapeutics Inc Pyrrole compounds
EP4070658A1 (de) 2021-04-06 2022-10-12 BIORoxx GmbH Verwendung von blutgerinnungshemmenden verbindungen als rodentizide

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3458515A (en) * 1966-07-21 1969-07-29 American Home Prod Piperazine substituted pyrroles
US20020061892A1 (en) * 2000-02-22 2002-05-23 Tao Wang Antiviral azaindole derivatives
US6861424B2 (en) 2001-06-06 2005-03-01 Schering Aktiengesellschaft Platelet adenosine diphosphate receptor antagonists
US6956040B2 (en) * 2001-07-16 2005-10-18 Ranbaxy Laboratories Limited Oxazolidinone piperazinyl derivatives as potential antimicrobials
CN1747732A (zh) 2002-12-11 2006-03-15 舍林股份公司 作为血小板腺苷二磷酸受体拮抗剂的2-氨基羰基喹啉化合物
WO2005009971A1 (ja) 2003-07-24 2005-02-03 Astellas Pharma Inc. キノロン誘導体又はその塩
US7273881B2 (en) * 2004-01-16 2007-09-25 Bristol-Myers Squibb Company Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
CN1778801A (zh) * 2004-11-22 2006-05-31 中国农业科学院兰州畜牧与兽药研究所 喹诺酮7-((4-((z)-2-(2-氨基-4-噻唑基)-2-甲氧亚胺乙酰基)-1-哌嗪基)化合物及其制备方法
WO2006073361A1 (en) * 2005-01-06 2006-07-13 Astrazeneca Ab Novel pyridine compounds
JP2008094720A (ja) 2005-01-20 2008-04-24 Astellas Pharma Inc キノロン誘導体のプロドラッグ又はその塩
EP1896483A2 (en) * 2005-03-28 2008-03-12 Pharmacia & Upjohn Company LLC 4-piperazinylthieno [2, 3-d] pyrimidine compounds as platelet aggregation inhibitors
CA2627719C (en) * 2005-11-03 2016-07-12 Portola Pharmaceuticals, Inc. [4-(6-halo-7-substituted-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylureas and forms and methods related thereto
WO2007103456A2 (en) * 2006-03-06 2007-09-13 Trimeris, Inc. Piperazine and piperidine biaryl derivatives

Similar Documents

Publication Publication Date Title
RU2424233C2 (ru) Производные бензимидазола, методы их получения, применение их в качестве агонистов фарнезоид-х-рецептора (fxr) и содержащие их фармацевтические препараты
JP2011507915A5 (enExample)
TWI326681B (en) 4,4,5,5 tetrasubstituted imidazolines
CA2535536C (en) Substituted 3-pyrrolidine-indole derivatives
US6573266B1 (en) Piperazine derivatives and their use as anti-inflammatory agents
JP2022506445A5 (enExample)
DE602004006431D1 (de) Derivate von n-äheteroaryl(piperidin-2-yl)methylübenzamid, verfahren zu deren herstellung und deren anwendung in therapeutika
JP2010539152A5 (enExample)
HRP20170338T1 (hr) Fluorometil-supstituirani pirolkarboksamidi
EP1735278A1 (en) Histamine h3 receptor agents, preparation and therapeutic uses
JP2010533722A5 (enExample)
RU2007128920A (ru) Производные хиназолина для торможения роста раковых клеток и способ их получения
JP2004508304A5 (enExample)
JP2016536333A5 (enExample)
CN1496981A (zh) 环胺衍生物及其作为药物的用途
ME02552B (me) Antagonisti piperidinon karboksamid azaindan cgrp receptora
RU2009132108A (ru) Иммунодепрессантные соединения и композиции
EA012703B1 (ru) Производные пиримидина и их применение в качестве модуляторов cb2
RU2463294C2 (ru) 1,3-дизамещенные 4-метил-1н-пиррол-2-карбоксамиды и их применение для изготовления лекарственных средств
MY150448A (en) 1- [2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of pain or residual symptoms in depression relating to sleep and cognition
US20030069245A1 (en) Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives
RU2419606C2 (ru) 3,4-замещенные производные пирролидина для лечения гипертензии
JP2007500705A5 (enExample)
CA2533812A1 (en) Substituted cycloalkylidene compounds
AU650825B2 (en) Disubstituted aryl compounds exhibiting selective leukotriene B4 antagonist activity